Food and Drug Administration import alerts affecting the following have been newly issued or modified in the past week.

- ampicillin from Ghana

- barbecue and other sauces from the Philippines

- basmati rice from Pakistan

- celery from Mexico

- cinnamon from Vietnam

- condoms from Thailand

- cooked shrimp from India

- crab from Chile

- dried barberries from Afghanistan

- dried bayberries from China

- dried mushrooms from China

- dried plums from Afghanistan

- eyeshadow from China

- frozen vacuum-packed fish from Ecuador

- long beans from Mexico

- mangosteens from Mexico

- medical instruments from Pakistan

- medicines from Canada

- multivitamin and other gummies from Canada

- noodles from India

- olive oil from Jordan

- orange beverage base from India

- pecans from Mexico

- raspberries from Mexico

- shampoo from India

- spinach powder from China

- tuna from Indonesia

- vapes from China

Import alerts inform FDA field staff that the agency has enough evidence or other information to allow a product that appears to be in violation of FDA laws and regulations to be detained without physical examination at the time of entry. Import alerts may cover products from designated countries or areas (including from all foreign countries), manufacturers, or shippers.

Firms and/or products on the “red list” of an import alert are subject to DWPE, while firms and/or products on the “green list” are not because they have met the criteria for exclusion. Some import alerts include a “yellow list” of firms, products, and/or countries subject to intensified surveillance because the nature of the violations may warrant further field examinations of individual entries and/or additional analyses. In addition, depending on the specific import alert, shipments of products subject to DWPE may still be imported into the U.S. if the importer has demonstrated that the shipment is in compliance.

If a product is detained without physical examination the importer has the right to provide evidence to the FDA in an attempt to overcome the appearance of the violation. If no such evidence is submitted, or if the evidence provided is insufficient, the product will be subject to refusal of entry into the U.S.

For more information on this and other FDA issues, please contact FDA consultant Domenic Veneziano at (202) 734-3939 or via email.

Copyright © 2024 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 


Cookie Consent

We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.